Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2023

Feb 3, 2023

29745_dirs_2023-02-03_782bafb5-6dd3-4a70-a521-25663a339a03.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2022-12-31

Reporting Person: Ricks David A (Director, President, Chair, and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-08-15 Common Stock G 32467 Disposed 365316 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 63500 Indirect
Common Stock 70000 Indirect
Common Stock 7169 Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F2: On May 11, 2022, the Reporting Person transferred 70,000 shares of Eli Lilly and Company common stock to a Grantor Retained Annuity Trust, of which the Reporting Person is the trustee.